Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Newsy

Published

Watch VideoDrugmaker Pfizer and its German partner BioNTech submitted an application for emergency use authorization for a COVID-19 vaccine. 

The companies say data shows the vaccine is 95% effective at preventing the disease. A second vaccine, from Moderna Inc., is showing similar results. 

The U.S. has a contract to buy...

Full Article